Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 1
A Phase 1, Single-Arm, Open-Label, Dose-Escalation, Multicenter Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of CS231295 in Patients With Advanced Solid Malignant Tumors
This is a Phase I, single-arm, open-label, dose-escalation, multicenter clinical study of CS231295 in patients with advanced solid malignant tumors. Eligible …
Advance Solid TumorsAdvanced Malignant Solid Tumors
Estimated
~$10 – $8,750
ThalassaX Therapeutics United States LtdNCT07612488
Phase 1
A Phase 1 Dose-Finding and Dose-Expansion Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
This is a 2-part, first-in-human, open-label study to determine the safety and tolerability of KIVU-107, a PTK7-directed antibody-drug conjugate, in participan…
Advance Solid Tumors
Estimated
~$10 – $8,750
Kivu Bioscience Inc.NCT07229313